Blood Builder Minis
MegaFood's Blood Builder Minis is a 'Botanical with Nutrients' product within the Vitamins & Minerals category, formulated with 5 ingredients. It holds an N+ Score of 71, earning a 'C' grade, indicating a good quality supplement. This product is designed to provide targeted support, with Folate (680 mcg DFE), Vitamin B12 (30 mcg), and Iron (26 mg) all present at clinically studied dosages, which research suggests may support healthy red blood cell formation. However, Vitamin C is included in an underdosed amount (15 mg). The supplement boasts 100% label transparency, ensuring all ingredient amounts are clearly disclosed. This product may be beneficial for individuals focusing on iron and B vitamin intake.
About This Product
Blood Builder Minis by MegaFood is a vitamins & minerals supplement containing 5 active ingredients. It has earned an N+ Score of 71/100 (Grade C).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Folate, Vitamin B12, Iron.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +3 ingredient(s) at clinical dose levels
Weaknesses
- −No major weaknesses identified
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Folate | 680.000 mcg DFE | Optimal |
| Vitamin B12 | 30.000 mcg | Optimal |
| Vitamin C | 15.000 mg | Under |
| Iron | 26.000 mg | Optimal |
| Beet | 188.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.